Skip To Main Content
Yingming Zhu on Muck Rack

Yingming Zhu

As seen in: Nature, Wiley Online Library, Frontiers, MDPI, ACS Publications, Royal Society of Chemistry, Emerald Publishing, Dialnet - Universidad de La Rioja, Chinese Management Studies
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingming

Contact Yingming, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A Facile In Situ Electroreduction to Construct a Nanoporous Silver Foams Membrane Electrode for Efficient CO 2 Reduction Click to copy article link Article link copied!

|
By Meng Yin, Yingming Zhu, Kejing Wu
| dx.doi.org
Open in Who Shared Issue with article?

Research on the impact mechanism of intergovernmental collaboration on cross-regional corporate cooperative behavior based on an evolutionary game analysis framework

|
By Renjun Xu, Jun Hu, Yingming Zhu, Yimiao Song
| Nature Verified
Abstract Under the context of advancing high-quality development, intergovernmental collaboration, as a pivotal governance approach, has emerged as a critical pathway to facilitating cross-regional enterprise cooperation, optimizing resource allocation, and enhancing overall competitiveness.
Open in Who Shared Issue with article?

Tumor microenvironment-oriented HNGCIscore identifies immunotherapy-sensitive subgroups in ICI retreatment of HER2-negative advanced gastric cancer

|
By Xuemin Song, Yiting Wu, Yingming Zhu, Yueqi He, Jinjun Shi, Ke Ren, Chanchan Gao
| Frontiers
Abstract Background: PD-1/PD-L1 inhibitor-based chemoimmunotherapy has become a standard first-line treatment for HER2-negative advanced gastric or gastro-esophageal junction cancer. However, most patients eventually experience disease progression, and optimal post-progression strategies, particularly immune checkpoint inhibitor (ICI)-based retreatment, remain unclear.
Open in Who Shared Issue with article?
See all 21 licensed articles (23 Total)